JP2016503812A5 - - Google Patents

Download PDF

Info

Publication number
JP2016503812A5
JP2016503812A5 JP2015550041A JP2015550041A JP2016503812A5 JP 2016503812 A5 JP2016503812 A5 JP 2016503812A5 JP 2015550041 A JP2015550041 A JP 2015550041A JP 2015550041 A JP2015550041 A JP 2015550041A JP 2016503812 A5 JP2016503812 A5 JP 2016503812A5
Authority
JP
Japan
Prior art keywords
formula
compound
process according
phenyl
lithium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015550041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016503812A (ja
JP6297590B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/077563 external-priority patent/WO2014102164A1/en
Publication of JP2016503812A publication Critical patent/JP2016503812A/ja
Publication of JP2016503812A5 publication Critical patent/JP2016503812A5/ja
Application granted granted Critical
Publication of JP6297590B2 publication Critical patent/JP6297590B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015550041A 2012-12-25 2013-12-20 1−([1,3]ジオキソラン−4−イルメチル)−1h−ピラゾール−3−イルアミンを調製するための方法 Active JP6297590B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2012/087380 2012-12-25
CN2012087380 2012-12-25
PCT/EP2013/077563 WO2014102164A1 (en) 2012-12-25 2013-12-20 Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine

Publications (3)

Publication Number Publication Date
JP2016503812A JP2016503812A (ja) 2016-02-08
JP2016503812A5 true JP2016503812A5 (enExample) 2016-12-22
JP6297590B2 JP6297590B2 (ja) 2018-03-20

Family

ID=49876646

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015550041A Active JP6297590B2 (ja) 2012-12-25 2013-12-20 1−([1,3]ジオキソラン−4−イルメチル)−1h−ピラゾール−3−イルアミンを調製するための方法

Country Status (23)

Country Link
US (1) US9388168B2 (enExample)
EP (1) EP2938609B1 (enExample)
JP (1) JP6297590B2 (enExample)
KR (1) KR102122569B1 (enExample)
CN (1) CN105051031B (enExample)
AU (1) AU2013369473B2 (enExample)
BR (1) BR112015015229B1 (enExample)
CA (1) CA2896155C (enExample)
CY (1) CY1119040T1 (enExample)
DK (1) DK2938609T3 (enExample)
ES (1) ES2629313T3 (enExample)
HR (1) HRP20170653T1 (enExample)
HU (1) HUE032621T2 (enExample)
IL (1) IL239558A (enExample)
LT (1) LT2938609T (enExample)
NZ (1) NZ709362A (enExample)
PL (1) PL2938609T3 (enExample)
PT (1) PT2938609T (enExample)
RU (1) RU2621725C2 (enExample)
SG (1) SG11201504951TA (enExample)
SI (1) SI2938609T1 (enExample)
WO (1) WO2014102164A1 (enExample)
ZA (1) ZA201504601B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11266630B2 (en) * 2016-12-15 2022-03-08 Hua Medicine (Shanghai) Ltd. Oral preparation of glucokinase activator and preparation method therefor
CN113493442B (zh) * 2020-04-03 2024-11-08 天津药物研究院有限公司 作为葡萄糖激酶活化剂的吡咯烷酮衍生物及其制备方法和用途
US11813274B2 (en) 2020-04-22 2023-11-14 Hua Medicine (Shanghai) Ltd. Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor
WO2021212360A1 (en) * 2020-04-22 2021-10-28 Hua Medicine (Shanghai) Ltd. Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor
CN111732543A (zh) * 2020-08-14 2020-10-02 浙江鼎龙科技有限公司 一种4,5-二氨基-1-(2-羟乙基)吡唑硫酸盐的制备方法
CN113750100B (zh) * 2021-08-31 2022-12-30 海南中济医药科技有限公司 一种含有多扎格列艾汀与西格列汀的药物组合物及其制备方法
AR127064A1 (es) * 2021-09-15 2023-12-13 Hua Medicine Shanghai Ltd Prodroga de derivados de pirrolidona como activador de glucoquinasa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160841A (en) * 1977-01-31 1979-07-10 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
FR2748274B1 (fr) * 1996-05-03 1998-06-12 Oreal Nouveaux diamino pyrazoles, leur synthese, compositions de teinture des fibres keratiniques les contenant, procede de teinture des fibres keratiniques
KR20100113518A (ko) * 2008-01-18 2010-10-21 아스텔라스세이야쿠 가부시키가이샤 페닐아세트아미드 유도체
US7741327B2 (en) * 2008-04-16 2010-06-22 Hoffmann-La Roche Inc. Pyrrolidinone glucokinase activators
US8178689B2 (en) * 2010-06-17 2012-05-15 Hoffman-La Roche Inc. Tricyclic compounds

Similar Documents

Publication Publication Date Title
JP2016503812A5 (enExample)
US7915412B2 (en) Process for the synthesis of 9-hydroxy risperidone (paliperidone)
JP6297590B2 (ja) 1−([1,3]ジオキソラン−4−イルメチル)−1h−ピラゾール−3−イルアミンを調製するための方法
EP2670751B1 (en) Methods of making hiv attachment inhibitor prodrug compound and intermediates
JP2014511387A5 (enExample)
WO2012174685A1 (zh) 一种2-取代-2h-1,2,3-三氮唑衍生物的制备方法
CN103483279B (zh) 一种1,4-二取代三氮唑化合物的制备方法
JP6014912B2 (ja) ベンダムスチンアルキルエステル、ベンダムスチン、およびそれらの誘導体の製造のためのプロセス
CN104684881A (zh) 羰基化合物的制备方法
US20150368206A1 (en) Methods for preparation of (4,6-dihalo-pyrimidin-5-yl)-acetaldehydes
JP6256484B2 (ja) ピリダジン化合物の製造方法
KR100745449B1 (ko) 벤조푸라논 옥심의 제조방법
JP2009527511A (ja) 3,4−ジ置換フェニル酢酸および新規な中間体の調製方法
JP5148836B2 (ja) ニコチン酸誘導体又はその塩の製造方法
RU2270195C1 (ru) Способ получения 5-амино-3-[n-ацил-n-алкиламино]-1-фенил-1,2,4-триазолов и 5-амино-3-[n-сульфонил-n-алкиламино]-1-фенил-1,2,4-триазолов
JP2006137711A (ja) ピリジン誘導体の製造方法
JP2008214192A (ja) モノアリルマロネートマグネシウム塩の結晶
HK1213262B (en) Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine
CN107857729A (zh) 一种4‑碘化‑n‑芳基化的吡唑类化合物的合成方法
JP2012051819A5 (enExample)
CN103709100A (zh) 一种8-氯代喹诺酮衍生物的制备方法
JP2003055343A (ja) ハロゲノメチルピロール化合物の製造方法及びハロゲノメチルピロール化合物